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1. Introduction 
The walls of Gram-positive bacteria contain acidic 
polysaccharides and teichoic acids that are covalently 
linked through phosphodiesters to muramic acid 
residues in the peptidoglycan. It has been shown 
recently that in St@yZococcus agrees H [ 1 ] and in a 
mutant strain that lacks N-acetylglucosaminyl sub- 
stituents on its wall teichoic acid [2] a ‘linkage unit’ 
that is a trimer of glycerol phosphate is interposed 
between the phosphate-terminal end of the teichoic 
acid chain and a muramic acid residue of the peptido- 
glycan to which it is attached. Evidence for similar 
linkage units has been found in Micrococcus sp. 2102 
and in Bacillus subtilis W32 [J. Coley and E. Tarelli, 
unpublished work]. 
None of the bacteria examined contains a glycerol 
teichoic acid in its wall, and it has been demonstrated 
that the glycerol membrane teichoic acids are 
synthesized from phosphatidylglycerol [3,4]. Never- 
theless, we have found [5] that membrane prepara- 
tions from all of them catalyse the synthesis from 
CDP-glycerol of material containing a glycerol phos- 
phate oligomer. Maximal synthesis of this product 
requires the addition of UDP-N-acetylglucosamine 
and the substrate for the synthesis of the backbone 
of the wall teichoic acid. The product is amphiphilic 
and appears to consist of the teichoic acid chain 
linked through the glycerol phosphate oligomer to a 
lipid acceptor. Bracha and Glaser [6] found that 
synthesis of the ribitol teichoic acid covalently linked 
to wall, in a wall-membrane preparation from S. aure’eus 
H, also required the addition of CDP-glycerol and 
UDP-N-acetylglucosamine. If therefore appears that 
teichoic acid attached to linkage unit is synthesized in 
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a membrane-bound form before it is transferred to 
the cell wall. 
When poly(ribito1 phosphate) is synthesized from 
labelled CDP-ribitol alone, in membranes of S. aureus 
H, a single product is formed which is poly(ribito1 phos 
phate) attached to lipoteichoic acid carrier (LTC) [7]. 
We report here that when CDP-glycerol and UDP-N- 
acetylglucosamine are also present, an additional 
poly(ribito1 phosphate) - containing product is 
obtained. This new material co-chromatographs with 
the material synthesized from CDP-[3H]glycerol in 
the presence of CDP-ribitol and UDP-N-acetyl- 
glucosamine. The antibiotic tunicamycin inhibits 
incorporation of glycerol phosphate from CDP- 
glycerol into membrane preparations and also inhibits 
formation of the second poly(ribito1 phosphate) 
species. These results can be explained by the earlier 
suggestion [S] that two different lipid carriers are 
involved in the synthesis of wall teichoic acid-linkage 
unit complexes. The inhibitory action tunicamycin 
suggests that one of these lipid carriers might be a 
polyisoprenyl phosphate. 
2. Methods 
CDP-[ l-3H]ribitol was synthesized enzymically 
from [ 1-3 H] ribitol Sphosphate and CTP using a crude 
CDP-ribitol pyrophosphorylase preparation from 
S. aureus H [8] . [ 1-3H] Ribitol Sphosphate was 
prepared by reduction of ribose S-phosphate with 
potassium [‘Hlborohydride. The specific activity of 
the CDP-ribitol was 75 &i/l_tmol. Preparation of the 
other substrates has been described previously [5]. 
Membranes were prepared from S. uureus H dis- 
75 
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rupted with glass beads as previously described [.5]. 
Membranes of B. subtilis W23 were obtained by lysis 
of the cells with lysozyme as described for Budus 
Zicheniformis [9]. Membranes were suspended in 
50 mM Tris-HCl, pH 8.0, containing 5 mM dithio- 
threitol, at 20 mg dry wt. of membrane/ml. 
Unglycosylated polyCribito1 phosphate) was obtain- 
ed by extraction with dilute alkali [lo] from walls of 
B. subtilis W23 mutant M3 that lacked glucosyl 
substituents on its wall teichoic acid. The walls were 
the generous gift of DI: A. R. Archibald. 
Incorporation of radioactivity into polymeric 
products was measured on paper as previously 
described [5]. For ion-exchange chromatography the 
products were isolated by a different procedure: to 
the reaction mixture (0.2 ml) was added 0.4 ml of 
propan-l-01 and the mixture was kept at room temper- 
ature for 15 min and then centrifuged at 1000 g for 
5 min. The resulting pellet was suspended in 0.8 ml 
of 50% (v/v) propanol for 15 min at room temperature 
and centrifuged again. Polymeric material was then 
extracted from the pellet into 0.4 ml of 1% (w/v) 
Triton X-100 at 60°C for 15 min and insoluble material 
was removed by centrifugation as before. Samples of 
the extracts were examined for the absence of residual 
labelled substrates by paper chromatography. Ion- 
exchange chromatography was carried out on a column 
(1.6 X 35 cm) of DEAE-cellulose (Whatman, DE52) 
equilibrated in 0.1% (w/v) Triton X-100 containing 
5 mM disodium EDTA (pH 4.5). The sample was 
applied in 2.0 ml of 0.5% (w/v) Triton X-100 and 
material was eluted with a linear gradient (200 ml) 
of 0 to 1 .O M sodium chloride in the equilibration solu- 
tion at a flow rate of 60 ml/h; 2.0 ml fractions were 
collected. 
Tunicamycin (Lot. No. T-12-06) was the generous 
gift of Professor G. Tamura. 
For assay of the glycosylation of added poly(ribito1 
phosphate) the incubation mixtures were as follows: 
S. aureus H membrane (2 mg dry wt. membrane), 
magnesium acetate (40 mM), UDP- [U-jH] -ZV-acetyl- 
glycosamine (0.025 PCi, 0.2 mM) or B. subtilis W23 
membrane (2.5 mg dry wt membrane), magnesium 
acetate (40 mM), UDP-[U-3H]gIucose (0.67 PCi, 
0.38 mM). Poly ribitol phosphate (containing 0.17 pmol 
phosphorus) was added where indicated. The total 
volume was 0.13 ml. Incorporation of radioactivity 
into polymeric products at 37’C during 1 h was meas- 
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ured by paper chromatography as previously describ- 
ed [5]. 
All measurements of radioactivity were carried out 
as previously described [5] . 
3. Results and discussion 
Figure 1 shows the separation of the labelled 
polymeric products from membranes of S. aureus H 
obtained from CDP-[3H]ribitol and UDP-N-acetyl- 
glucosamine in the presence and absence of CDP- 
glycerol. Formation of the major product obtained 
in the absence of CDP-glycerol (Rl) was unaffected 
by the omission of UDP-N-acetylglucosamine, but 
this nucleotide greatly stimulated the formation of 
the additional component (R2) that was synthesized 
in the presence of CDP-glycerol. Both Rl and R2 
gave radioactive anhydroribitol and ribitol phos- 
phates, with smaller amounts of ribitol, on acid 
hydrolysis. These are the hydrolysis products expected 
from poly(ribito1 phosphate). Radioactive polymer 
synthesized from CDP-[3H]glycerol in the presence 
of CDP-ribitol and UDP-N-acetylglucosamine [5] was 
40 60 80 
fraction 
Fig.1. Ion-exchange chromatography of radioactive poly(ribito1 
phosphate) synthesized in the presence o-o, and absence 
o---o of CDP-glycerol. 1 ml samples of each fraction were 
counted for radioactivity. The counts shown have not been 
corrected for background or variation in counting efficiency. 
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eluted from the column as a single component coin- 
cident with R2; it is probably therefore that R2 is 
identical with the polymer labelled from CDP-glycerol. 
Synthesis of polymer from CDP-[3H]glycerol in 
the presence of CDP-ribitol and UDP-N-acetylglucos- 
amine was strongly inhibited by the antibiotic tunica- 
mycin in both S. aureus and B. subtilis. In S. aureus H 
50% inhibition was caused by 1 pg of antiobiotic/ml. 
At 3 pg of antibiotic/ml glycerol incorporation was 
inhibited by 80%, and at concentrations above 10 pg 
antibiotic/ml inhibition was about 90%. 3 pg of 
tunicamycin/ml did not inhibit incorporation of ribitol 
phosphate from CDP-ribitol alone, but caused 40% 
inhibition when CDP-glycerol and UDP-N-acetylglucos- 
amine were also present (table 1). Figure 2 shows that 
almost all the inhibition of ribitol incorporation in 
the presence of CDP-glycerol and UDP-N-acetyl- 
glucosamine was because of inhibition of the synthesis 
of component R2 and not of Rl. The residual material 
in R2 was eluted slightly later than the bulk of the 
material in R2 from the uninhibited preparation. This 
may indicate that R2 is heterogeneous, but we have 
been unable to obtain any further resolution within 
the peak. 
Qualitatively similar results were obtained using a 
600 
r 
fraction 
__ __ 
Fig.2. Ion-exchange chromatography of radioactive poly(ribito1 
phosphate) synthesized in the presence of UDP-N-acetyl- 
glucosamine and CDP-glycerol. o-o no tunicamycin; 
l - - - -0 3 fig tunicamycin/ml. 
membrane preparation from B. subtilis W23 (table l), 
which contains a glucosylated poly(ribito1 phosphate) 
in its wall. On storage, frozen at -20°C the membrane 
preparation gradually lost the ability to synthesize R2 
during a period of 2 months, but retained full activity 
for synthesizing RI. This ageing effect was responsible 
for the discrepancy between the proportions of Rl 
and R2 in the two experiments with CDP-glycerol 
and UDP-N-acetylglucosamine shown in table 1. 
One notable difference between the behaviour of 
the two bacterial systems was in the effect of CDP- 
glycerol together with UDP-N-acetylglucosamine on 
the total incorporation of label from CDP-ribitol into 
polymeric products. In B. subtilis membranes the two 
added nucleotides increased overall poly(ribito1 phos- 
phate) synthesis by about 77%, whereas they inhibited 
in S. aureus by about 30%. 
Fiedler and Glaser [7 ] obtained a fraction from 
triton-solubilized membranes of S. aureus H that 
catalysed the synthesis of poly(ribito1 phosphate) from 
CDP-ribitol in the presence of added acceptor. The 
acceptor had the properties of a membrane teichoic 
acid and was named lipoteichoic acid carrier (LTC). 
A single polymeric product was obtained that consisted 
of a complete poly(ribito1 phosphate) chain com- 
prising about forty ribitol phosphate residues linked 
through its phosphate terminal end to an unknown 
position on LTC. It is likely that the major component 
RI of the poly(ribito1 phosphate) synthesized from 
CDP-ribitol alone in our systems is also poly(ribito1 
phosphate)-LTC. In the presence of CDP-glycerol and 
UDP-N-acetylglucosamine an additional ribitol-con- 
taining polymer (R2) is formed, which appears to be 
identical with the polymer synthesized from labelled 
CDP-glycerol in the presence of UDP-N-acetylglucos- 
amine and CDP-ribitol. We believe that this product 
consists of a poly(ribito1 phosphate) chain linked 
through its terminal phosphate to the tri(glycero1 
phosphate) linkage unit described by Heckels, 
Archibald and Baddiley [2] which is in turn linked to 
an unidentified lipid acceptor [S] . Although it seems 
probable that the poly(ribito1 phosphate) moiety of 
R2 originated in Rl, we have no direct evidence to 
confirm this. 
Tunicamycin completely inhibited incorporation 
from CDP-[3H]glycerol into R2, but only partly 
inhibited incorporation from CDP- [ 3H] ribitol, in 
S. aureus H. It therefore appears that tunicamycin 
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Table 1 
Incorporation into polymers from CDP-[ ‘Hlribitol and CDP-[ ‘HIglycerol by membrane 
preparations from B. subtilis W23 and S. aureus H 
October 1976 
Bacterium Substrates Total ‘H in % Total [3H]Polymer 
polymers (cpm) Rl R2 
B. subtilis W23 Fresh membranes CDP-[ ‘Hlribitol 
CDP-[ “Hlribitol 
CDP-glycerol 
UDP-N-acetylglucosamine 
4578 >90 < 10 
7124 64 36 
Aged membranes CDP-[ “Hlribitol 
CDP-glycerol 
UDP-N-acetylglucosamine 
5760 23 77 
as above 
+ tunicamycin 
CDP-[ 3H]ribitol 
CDP-[ 3H]ribitol 
GDP-glycerol 
UDP-N-acetylglucosamine 
3908 43 57 
7208 >90 < 10 
SO!6 35 65 
S. aureus H 
as above 
+ tunicamycin 
CDP-[ sH]glycerol 
CDP-[ ‘HIglycerol 
UDP-N-acetylglucosamine 
CDP-ribitol 
3010 53 47 
235 not detectable 
5540 _ 100 
as above 
+ tunicamycin 466 not detectable 
inhibits the synthesis of the tri(glycero1 phosphate)- 
acceptor unit that is dependent upon UDP-N-acetyl- 
glucosamine, but does not inhibit synthesis of RI. 
Possibly the membrane contained sufficient endogenous 
linkage unit-acceptor to allow some synthesis of R2 
in the absence of CDP-glycerol and UDP-N-acetyl- 
glucosamine; synthesise of R2 from this material 
would not be inhibited by tunicamycin. 
Tunicamycin is known to inhibit the synthesis of a 
polyisoprenyl pyrophosphate N-acetylglucosamine 
that is involved in the biosynthesis of a yeast glyco- 
protein [ 1 l] and a mammalian cell surface glyco- 
protein [ 121. Bettinger and Young [ 131 and Tamura 
et al. [14] have also demonstrated that it inhibits 
the biosynthesis of peptidoglycan in bacteria, but 
have obtained contradictory evidence about the precise 
site of action of the antibiotic. In membranes of 
Bacillus subtilis 168 tunicamycin at a concentration 
of 15 gg/ml inhibited synthesis of the first lipid inter- 
78 
mediate, polyisoprenyl pyrophosphate N-acetyl- 
muramyl pentapeptide by less than 10% [ 131 and 
Bettinger and Young therefore concluded that the 
antibiotic inhibited the addition of N-acetylglucos- 
amine to this lipid to form the disaccharide lipid 
intermediate N-acetylglucosaminyl-N-acetylmuramyl 
pentapeptide pyrophosphate polyisoprenol. On the 
other hand in a cell-free membrane preparation from 
Micrococcus lysodeikticus tunicamycin at 50 pg/ml 
inhibited synthesis of the first lipid intermediate by 
83% but was far less inhibitory towards the synthesis 
of the disaccharide lipid [ 141. Although the precise 
specificity of the antibiotic is therefore uncertain, 
the evidence indicates that at the low concentrations 
used in our experiments it is an inhibitor of reactions 
between N-acetylhexosamine-containing nucleotides 
and lipids containing a poll isoprenyl phosphate 
moiety [ 121. Tunicamycin did not inhibit the glycosyla- 
tion of exogenous poly(ribito1 phosphate) either by 
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CDP-ribitol CMP 
LTC J’ qibitol)s6 
I WALL 
AcceptorIP-glycerolI 
x 
CMP 
Tunicamycin 
Acceptor CDP-glycerol 
+ UDPGlcNAc 
Fig.3. Suggested scheme for the assembly of teichoic acid-linkage unit. 
UDP-N-acetylglucosamine in membranes of S. aureus 
H or by UDP-glucose in membranes of B. subtilis 
W23. Therefore, the appearance of tunicamycin-sensi- 
tive material in peak R2 is not due to the synthesis of 
the glycosylated derivative of Rl in either case. 
Conclusions from these studies are summarized in 
the scheme (fig.3) for the biosynthesis of wall teichoic 
acid-linkage unit and its transfer to peptidoglycan to 
form wall material. Two different acceptors are 
required; one of these (LTC) is identical to or similar 
to the membrane teichoic acid and this accepts ribitol 
phosphate residues from CDP-ribitol to build up the 
main chain of the wall teichoic acid. The synthesis of 
the poly(ribito1 phosphate)-LTC (peak Rl) is not 
inhibited by tunicamycin. The second acceptor occurs 
in the butanol soluble fraction from membranes [5] 
and receives three glycerol phosphate residues from 
CDP-glycerol to form the linkage unit. The teichoic 
acid main chain is transferred from poly(ribito1 phos- 
phate)-LTC to this lipid containing the linkage unit to 
give a water-soluble amphiphilic product (R2), the 
formation of which is strongly inhibited by tunica- 
mycin. Thus R2 comprises poly(ribito1 phosphate)- 
linkage unit-lipid acceptor, and it is this that partici- 
pates in the attachment of teichoic acid to peptido- 
glycan. As tunicamycin powerfully inhibits the 
synthesis of R2, which is dependent upon UDP-IV- 
acetylglucosamine, it is likely that the synthesis 
requires a polyisoprenyl phosphate derivative. This is 
in agreement with the previous suggestion [5] that 
the second lipid acceptor might be the polyprenyl 
pyrophosphate N-acetylmuramyl pentapeptide N-acetyl. 
glucosamine intermediate in peptidoglycan synthesis, 
although other possible polyisoprenyl phosphate con- 
taining N-acetylglucosamine have not been excluded. 
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